✦ LIBER ✦

Phase II study of carboplatin in blast crisis of chronic myeloid leukemia: Eastern Cooperative Oncology Group Study E1992

✍ Scribed by Dutcher, J P; Lee, S; Paietta, E; Bennett, J M; Stewart, J A; Wiernik, P H

Book ID: 110053879
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 36 KB
Volume: 12
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2401056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of theophylline in chroni

Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)

✍ Wiernik, P H; Paietta, E; Goloubeva, O; Lee, S J; Makower, D; Bennett, J M; Wade 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

A pilot study of carboplatin and mitoxan

A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemia

✍ Janice P. Dutcher; Evelyn L. Morris; Bruce Gaynor; Elisabeth Paietta; Peter H. W 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 229 KB

Phase II trial of 2-chlorodeoxyadenosine

Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: A study of the Eastern Cooperative Oncology Group (ECOG), E5995

✍ Michael S Gordon; Molly L Young; Martin S Tallman; Larry D Cripe; John M Bennett 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 70 KB

13-cis-retinoic acid in the treatment of

13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the eastern cooperative oncology group

✍ Zachary B. Kramer; Laszlo Boros; Peter H. Wiernik; Janet Andersen; John M. Benne 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

The management of acute myeloid leukemia in the elderly (65 years and older) is unsatisfactory because of poor patient tolerance of standard myeloablative chemotherapy. The authors conducted a Phase II study to evaluate the effectiveness and toxicity of 13-cis-retinoic acid (CRA) in the therapy of e

Docetaxel for Malignant Mesothelioma: Ph

Docetaxel for Malignant Mesothelioma: Phase II Study of the Eastern Cooperative Oncology Group

✍ Chandra P. Belani; Sudeshna Adak; Seena Aisner; Philip J. Stella; Nathan Levitan 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 146 KB

Phase II trial of PCNU in advanced malig

Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study

✍ Robert H. Earhart; Franco M. Muggia; Frederick M. Golomb 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 327 KB

PCNU, a chloroethylnitrosourea with high alkylating activity, low carbamoylating activity, optimal octanol: water partition coefficient and broad activity in animal systems, was administered to 32 evaluable patients with measurable metastatic melanoma by brief intravenous infusions every six weeks.